Prophylaxis News and Research

RSS
Working Towards a Sustainable Future for the NHS

Working Towards a Sustainable Future for the NHS

UNC researchers awarded $3.8 million grant to develop ultra-long-acting antiretroviral formulations

UNC researchers awarded $3.8 million grant to develop ultra-long-acting antiretroviral formulations

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Joint research team discovers potential new treatment for severe malaria

Joint research team discovers potential new treatment for severe malaria

UIC receives grant to reduce sexually transmitted infections among South African women

UIC receives grant to reduce sexually transmitted infections among South African women

FDA approves HEMLIBRA for treatment of hemophilia A

FDA approves HEMLIBRA for treatment of hemophilia A

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Risk-profiling can help improve preventive measures against HIV

Risk-profiling can help improve preventive measures against HIV

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Australia's HIV diagnoses hit seven year low

Australia's HIV diagnoses hit seven year low

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

SLU's College professor receives NIH grant to develop I-TEST project

SLU's College professor receives NIH grant to develop I-TEST project

New program combines basic science and social benefits to address HIV risk among young women

New program combines basic science and social benefits to address HIV risk among young women

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

CNS releases new clinical practice guidelines for thoracolumbar spine trauma

CNS releases new clinical practice guidelines for thoracolumbar spine trauma

Subcutaneous injection of new protein helps treat hemophilia more effectively

Subcutaneous injection of new protein helps treat hemophilia more effectively

Understanding How Antibodies Shape the Gut Microbiome

Understanding How Antibodies Shape the Gut Microbiome